To determine whether it can affect the genes downstream of β-catenin/TCF4/LEF-1, the human global gene expression profiles of three independent RNA samples from the breast cancer cells treated with TAT-NLS-BLBD-6 and TAT-NLS-BLBD-6m were examined (Fig. 6a). Here, LEF1 is linked to breast carcinoma.